Disulphide-reduced psoriasin is a human apoptosisinducing broad-spectrum fungicide

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 42, 2015, Pages 13039-13044

  Hein, Kyaw Zaw ^a,h   Takahashi, Hitoshi ^a   Tsumori, Toshiko ^a,b   Yasui, Yukihiko ^a   Nanjoh, Yasuko ^c   Toga, Tetsuo ^c   Wu, Zhihong ^d   Grötzinger, Joachim ^e   Jung, Sascha ^e   Wehkamp, Jan ^f,g   Schroeder, Bjoern O ^f,i   Schroeder, Jens M ^d   Morita, Eishin ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^c NIHON NOHYAKU CO LTD   (Japan)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g ROBERT BOSCH HOSPITAL   (Germany)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE; DISULFIDE; DISULPHIDE REDUCED PSORIASIN; FUNGICIDE; GLUTATHIONE; PSORIASIN; THIOREDOXIN; UNCLASSIFIED DRUG; ZINC ION; ANTIFUNGAL AGENT; PROTEIN S 100; S100A7 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; APOPTOSIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; FILAMENTOUS FUNGUS; FUNGAL CELL; IMMUNOGOLD ELECTRON MICROSCOPY; IN VIVO STUDY; LUNG INFECTION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PURIFICATION; SKIN INFECTION; TRICHOPHYTON RUBRUM; TUNEL ASSAY; ZINC HOMEOSTASIS; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GUINEA PIG; HUMAN; MICROBIAL SENSITIVITY TEST; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIFUNGAL AGENTS; APOPTOSIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; DISEASE MODELS, ANIMAL; DISULFIDES; GUINEA PIGS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; OXIDATION-REDUCTION; S100 PROTEINS;

EID: 84947776178     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1511197112     Document Type: Article

References (41)

1. Brown GD, Denning DW, Levitz SM (2012) Tackling human fungal infections. Science 336(6082):647.
2. Fisher MC, et al. (2012) Emerging fungal threats to animal, plant and ecosystem health. Nature 484(7393):186-194.
3. Brown GD, et al. (2012) Hidden killers: Human fungal infections. Sci Transl Med 4(165):165rv13.
4. Brakhage AA (2005) Systemic fungal infections caused by Aspergillus species: Epidemiology, infection process and virulence determinants. Curr Drug Targets 6(8): 875-886.
5. Findley K, et al.; NIH Intramural Sequencing Center Comparative Sequencing Program (2013) Topographic diversity of fungal and bacterial communities in human skin. Nature 498(7454):367-370.
6. Osherov N (2012) Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells. Front Microbiol 3:346.
7. Schroeder BO, et al. (2011) Reduction of disulphide bonds unmasks potent antimicrobial activity of human p-defensin 1. Nature 469(7330):419-423.
8. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32(6):982-986.
9. Harder J, Bartels J, Christophers E, Schroder JM (1997) A peptide antibiotic from human skin. Nature 387(6636):861.
10. Harder J, Schroder JM (2005) Psoriatic scales: A promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77(4):476-486.
11. Glaser R, et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6(1):57-64.
12. Mildner M, et al. (2010) Psoriasin (S100A7) is a major Escherichia coli-cidal factor of the female genital tract. Mucosal Immunol 3(6):602-609.
13. Meyer JE, et al. (2008) Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue. Mucosal Immunol 1(3):239-243.
14. Brodersen DE, Nyborg J, Kjeldgaard M (1999) Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 38(6):1695-1704.
15. Maret W, Li Y (2009) Coordination dynamics of zinc in proteins. Chem Rev 109(10): 4682-4707.
16. Michalek M, et al. (2009) The human antimicrobial protein psoriasin acts by per-meabilization of bacterial membranes. Dev Comp Immunol 33(6):740-746.
17. Brophy MB, Hayden JA, Nolan EM (2012) Calcium ion gradients modulate the zinc affinity and antibacterial activity of human calprotectin. JAm ChemSoc 134(43):18089-18100.
18. Kimura E, Aoki S (2001) Chemistry of zinc(II) fluorophore sensors. Biometals 14(3-4): 191-204.
19. Zalewski PD, Forbes IJ, Betts WH (1993) Correlation of apoptosis with change in in-tracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy) acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296(Pt 2):403-408.
20. Radford RJ, Lippard SJ (2013) Chelators for investigating zinc metalloneurochemistry. Curr Opin Chem Biol 17(2):129-136.
21. Loomans HJ, Hahn BL Li QQ, Phadnis SH, Sohnle PG (1998) Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. JlnfectDis 177(3):812-814.
22. Ungpakorn R, Holdom MD, Hamilton AJ, Hay RJ (1996) Purification and partial characterization of the Cu,Zn superoxide dismutase from the dermatophyte Tricho-phyton mentagrophytes var. interdigitale. Clin Exp Dermatol 21(3):190-196.
23. Gamen S, et al. (2000) Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells. Exp Cell Res 258(1):223-235.
24. Shindo Y, Witt E, Han D, Epstein W, Packer L (1994) Enzymic and non-enzymic anti-oxidants in epidermis and dermis of human skin. J Invest Dermatol 102(1):122-124.
25. Arner ES, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267(20):6102-6109.
26. Schallreuter KU, Wood JM (1986) The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun 136(2): 630-637.
27. Lechenne B, et al. (2007) Sulphite efflux pumps in Aspergillus fumigatus and dermatophytes. Microbiology 153(Pt 3):905-913.
28. Koga H, Nanjoh Y, Kaneda H, Yamaguchi H, Tsuboi R (2012) Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Antimicrob Agents Chemother 56(6):3138-3143.
29. Gaziano R, et al. (2004) Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 48(11):4414-4421.
30. Lulloff SJ, Hahn BL, Sohnle PG (2004) Fungal susceptibility to zinc deprivation. J Lab Clin Med 144(4):208-214.
31. Zhang Y, Cougnon FBL, Wanniarachchi YA, Hayden JA, Nolan EM (2013) Reduction of human defensin 5 affords a high-affinity zinc-chelating peptide. ACS Chem Biol 8(9): 1907-1911.
32. Ghannoum MA, Rice LB (1999) Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12(4):501-517.
33. Nakatani T, Tawaramoto M, Opare Kennedy D, Kojima A, Matsui-Yuasa I (2000) Apo-ptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chem Biol lnteract 125(3):151-163.
34. Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M (2012) TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways. Oxid Med Cell Longev 2012:313275.
35. Linder MB, Szilvay GR, Nakari-Setala T, Penttila ME (2005) Hydrophobins: The protein-amphiphiles of filamentous fungi. FEMS Microbiol Rev 29(5):877-896.
36. Bayry J, Aimanianda V, Guijarro JI, Sunde M, Latge JP (2012) Hydrophobins-Unique fungal proteins. PLoS Pathog 8(5):e1002700.
37. Paris S, et al. (2003) Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol 69(3):1581-1588.
38. Romani L (2011) Immunity to fungal infections. Nat Rev lmmunol 11(4):275-288.
39. Schroder JM (2010) Purification of antimicrobial peptides from human skin. Methods Mol Biol 618:15-30.
40. Schroeder JM (2010) in Isolation and Characterization of Human Epithelial Antimicrobial Peptides and Proteins, eds Kabelitz D, Kaufmann SHE, Methods in Microbiology (Academic, Amsterdam), Vol 37, pp 115-138.
41. Espinel-Ingroff A, Chaturvedi V, Fothergill A, Rinaldi MG (2002) Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol 40(10):3776-3781.